Offer - Urjas Oil for just ₹ 1 X
Glynit 2.6 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Angina. Secondary and off-label uses of Glynit 2.6 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Glynit 2.6 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Glynit 2.6 Tablet include Dizziness, Weakness, Drowsiness. Some other side effects of Glynit 2.6 Tablet have been listed ahead. These side effects of Glynit 2.6 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Glynit 2.6 Tablet's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if Glynit 2.6 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glynit 2.6 Tablet related warnings section.
Individuals suffering from medical conditions like Anemia must refrain from the use of Glynit 2.6 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Glynit 2.6 Tablet contraindications section.
Drug reaction of Glynit 2.6 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Glynit 2.6 Tablet is considered not safe while driving, and is not addictive.
Glynit 2.6 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glynit 2.6 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Glynit in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Glynit 2.6 Tablet safe during breastfeeding?
Information about safety of Glynit for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Glynit 2.6 Tablet on the Kidneys?
Glynit is not harmful for kidneys.
What is the effect of Glynit 2.6 Tablet on the Liver?
Information about safety of Glynit for the liver is not available since scientific research on this is yet to be done.
What is the effect of Glynit 2.6 Tablet on the Heart?
Very few cases of side effects of Glynit on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Glynit 2.6 Tablet unless your doctor advises you to do so -
Is this Glynit 2.6 Tablet habit forming or addictive?
No, there is no any evidence that Glynit 2.6 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Glynit 2.6 Tablet. So it is best to avoid driving.
Is it safe?
Glynit 2.6 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Glynit 2.6 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Glynit 2.6 Tablet
Using Glynit 2.6 Tablet with some foods may lead to harmful effects. Take your doctor's advice on this.
Interaction between Alcohol and Glynit 2.6 Tablet
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (Nitroglycerin Sublingual)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540